There’s a facelift for ddn
beginning in December, and some new directions for coverage going into 2013. With regard to that and more, the magazine’s chief editor, Amy Swinderman, walks
you through some of the highlights of the past year and what’s in store for the future
The terms “drug-like” and “drug-like properties” have gained common currency in the drug discovery community.
They usually refer to the values of simple physicochemical and structural compound properties that successful drugs have in common. However, despite the
frequency with which these terms are used, “drug-like” means different things to different people and will depend on a project’s specific objective